Haleon (HLN) Cash & Current Investments (2021 - 2025)

Haleon (HLN) posted Cash & Current Investments of $1.9 billion for Q4 2025, down 38.95% on a QoQ basis from $3.1 billion in Q4 2024, and down 38.95% year-over-year from $3.1 billion in Q4 2024.

Haleon (HLN) Cash & Current Investments (2021 - 2025) Analysis & Trends

Haleon's Cash & Current Investments history runs 5 years deep, the most recent figure standing at $1.9 billion for Q4 2025.

  • Quarterly Cash & Current Investments fell 38.95% year-over-year to $1.9 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.9 billion (down 38.95% YoY) and the FY2025 annual result came in at $1.8 billion, down 39.24% from the prior year.
  • Cash & Current Investments was $1.9 billion for Q4 2025 at Haleon, down from $3.1 billion in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $3.1 billion in Q4 2024 and bottomed at $381.7 million in Q2 2023.
  • A 5-year average of $1.3 billion and a median of $1.1 billion in 2023 frame the typical range for Cash & Current Investments.
  • Annual changes were most pronounced in 2023 — Cash & Current Investments slumped 79.52% — and 2024, when it surged 130.67%.
  • Haleon's Cash & Current Investments stood at $564.8 million in 2021, then surged by 52.43% to $860.9 million in 2022, then soared by 53.82% to $1.3 billion in 2023, then jumped by 130.67% to $3.1 billion in 2024, then slumped by 38.95% to $1.9 billion in 2025.
  • Business Quant data shows HLN's Cash & Current Investments at $1.9 billion in Q4 2025, $3.1 billion in Q4 2024, and $541.5 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - 1.86 Bn
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 3.74 Bn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 1.94 Bn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn 4.06 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 2.15 Bn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 1.80 Bn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 1.32 Bn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 428.00 Mn
10 Vireo Growth 10.53 Bn 10.38 Bn 59.30 Mn 153.20 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.86 Bn
Dec 31, 2024 3.05 Bn
Jun 30, 2024 541.49 Mn
Dec 31, 2023 1.32 Bn
Jun 30, 2023 381.67 Mn
Dec 31, 2022 860.93 Mn
Jun 30, 2022 1.86 Bn
Dec 31, 2021 564.82 Mn